Sponsor or institution
Clinical trials and research at Versiti Wisconsin, INC.
As of November 12, 2026, Find a Trial lists 39 NIH-funded research projects at this institution, with $23.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 39NIH research projects
NIH-funded research (39)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Improving blood safety and availability for transfusions in children and adults
This study is looking to make blood transfusions safer and more accessible for both kids and adults by gathering information from blood donors and recipients across the US and Brazil, so that everyone can benefit from better transfusion practices in the future.
-
Understanding how to safely increase fetal hemoglobin for treating blood disorders
This study is looking at how to safely boost fetal hemoglobin levels in people with blood disorders like beta-thalassemia, by exploring new ways to change certain cells in the body, so that patients can have better treatment options.
-
Understanding how certain proteins regulate blood clotting and cardiovascular diseases
This study is looking at how two proteins that help with blood clotting and heart health work, which could lead to better treatments for blood clotting disorders and heart disease.
-
Targeting a specific gene to treat a type of leukemia
This study is testing a new treatment called AI-10-49 for people with acute myeloid leukemia who have a specific genetic change that makes their condition harder to treat, and it aims to help these patients live longer by killing leukemia cells and working better with other medications.
-
Understanding maternal immune responses affecting newborns with low platelet counts
This study is looking at how a mother's immune system can affect her baby's platelets, which might lead to a serious bleeding condition in newborns, and it aims to find out which pregnancies are at higher risk so that better tests and prevention methods can be developed to help keep babies safe.
-
Understanding the immune response in patients with heparin-induced thrombocytopenia
This study is looking at how the immune system responds to heparin, a blood thinner, to find out more about a serious condition called heparin-induced thrombocytopenia (HIT), and it aims to help doctors better identify harmful antibodies in patients, even if their regular tests come back normal, so they can prevent ser
-
Understanding liver crises in sickle cell disease
This study is looking into how sickle cell disease can harm the liver and cause serious problems, with the hope of finding new ways to help prevent these issues for patients.
-
Investigating the immune response and blood clotting issues in severe COVID-19 cases
This study is looking at how the immune system reacts to the COVID-19 virus and why some people get really sick with blood clots, hoping to find ways to improve treatments for everyone affected by the virus.
-
Understanding how blood cell clots cause lung injury in sickle cell disease
This study is looking into how certain tiny clots in the lungs can make Acute Chest Syndrome worse for people with Sickle Cell Disease, and it hopes to find new ways to prevent or lessen this serious condition.
-
Investigating how kindlin-3 affects neutrophil function in inflammation
This study is looking at how a protein called kindlin-3 helps white blood cells called neutrophils do their job better during inflammation, which could lead to new ways to treat ongoing inflammatory conditions while protecting healthy tissues.
-
Targeting a key metabolic regulator in acute myeloid leukemia
This study is looking at how a protein called SIRT5 helps blood cancer cells survive, with the hope of finding new ways to treat acute myeloid leukemia (AML) and improve outcomes for patients.
-
Targeting complex mutations in leukemia treatment
This study is looking at a new drug called asciminib to see if it can help people with a tough type of leukemia that has not responded to standard treatments, especially those with multiple gene mutations.
-
How a protein called Rap1 affects heart function
This study is looking at a protein called Rap1 to see how it helps heart cells talk to each other and affects blood flow, which could lead to better treatments for heart disease and heart failure.
-
Understanding the role of MS4A3 in blood cell development and leukemia
This study is looking at how a protein called MS4A3 influences blood cell development and the progression of chronic myeloid leukemia, especially for patients whose leukemia doesn't respond to regular treatments, with the hope of finding new ways to help improve their care.
-
Investigating how certain vesicles affect blood clotting in sickle cell disease
This study is looking at how tiny particles in the blood, called extracellular vesicles, might affect blood clots in the lungs of people with sickle cell disease, with the goal of finding better ways to diagnose and treat this serious problem.
-
Understanding how specific molecules affect blood cell formation
This study is looking at how certain sugars in the body, called glycosaminoglycans, help make and support blood cells in the bone marrow, with the goal of finding new ways to treat blood disorders.
-
Understanding how sugars on blood cells affect their production
This study is looking at how sugars on blood cells and in their surroundings help control the production of blood cells, like platelets, to find ways to improve their formation and function for better health.
-
Understanding how megakaryocytes support blood cell production
This study is looking at how certain blood cells help make platelets, especially for people who have low platelet counts after treatments like chemotherapy or stem cell transplants, with the goal of finding better ways to boost platelet production and reduce the need for transfusions.
-
Investigating the role of glycosaminoglycans in blood cell development
This study is looking at special sugars in bone marrow that help with blood cell development, and it aims to learn how these sugars work with proteins, which could lead to better treatments for blood disorders.
-
Investigating how sugars affect blood cell function and health
This study is looking at how adding sugars to proteins affects the health and behavior of blood cells, helping us understand how these changes might influence blood cell function and development.
-
Coordinating administrative support for blood research
This study is all about helping scientists work better together to learn more about how certain sugars in the blood relate to blood diseases, which could eventually lead to better treatments for patients like you.
-
Understanding how sugars influence blood cell production in the bone marrow
This study is looking at how certain sugars in your body help make and manage blood cells in the bone marrow, which could lead to new ways to treat blood disorders.
-
A symposium focused on advancing glycobiology research and supporting emerging scientists.
The 2024 Translational Glycomics Symposium is a friendly gathering for new researchers and trainees to learn about the study of sugars in our bodies, with talks from experts on topics like aging, inflammation, and cancer, and it encourages everyone to connect and share ideas, especially those from underrepresented back
-
How a specific protein in blood vessels helps control inflammation in the retina
This study is looking at how a protein called Rap1B in the cells of your eye's blood vessels helps control inflammation, which is important for people with Diabetic Retinopathy, and aims to find new ways to prevent vision loss by understanding how this protein interacts with other cells in the eye.
-
Investigating how a specific protein affects blood and endothelial cell communication during coronavirus infection
This study is looking at how a specific protein in your blood cells interacts with the coronavirus and helps cells communicate, which could help us understand and improve treatments for COVID-19 complications.
-
Understanding vaccine-related blood clotting issues
This study is looking into a rare but serious condition called vaccine-induced immune thrombotic thrombocytopenia (VITT) that can happen after getting certain COVID-19 vaccines, and it aims to understand how specific antibodies in the blood might cause this issue, so that doctors can find better ways to diagnose and tr
-
Understanding the immune response in heparin-induced thrombocytopenia
This study is looking to create a quick and reliable test to help doctors tell the difference between harmful and harmless antibodies in patients who have had a serious reaction to heparin, which could lead to better treatment and outcomes for those affected.
-
Understanding a bleeding disorder in newborns caused by maternal antibodies
This study is looking into Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT), a condition where a mother's antibodies can harm her baby's platelets, which might cause serious bleeding; researchers are using animal models to learn more about how these antibodies work so they can find better ways to diagnose and treat b
-
Investigating antibody-mediated blood disorders and their underlying mechanisms
This study is looking at how certain antibodies can cause blood disorders by affecting platelets, and it's aimed at helping people with autoimmune thrombocytopenias by finding better treatments.
-
Centralized support for blood research projects
This study is all about helping researchers at the Blood Research Institute work better together on projects related to blood disorders, which could lead to better treatments for patients with autoimmune thrombocytopenias and similar conditions.
-
Understanding how immune responses affect blood platelet levels
This study is looking into how the immune system affects low platelet counts and blood clotting issues, with the goal of finding better treatments for people of all ages, from newborns to adults.
-
Investigating a new RNA therapy to reduce bleeding by controlling fibrinolysis
This study is looking at how a process that breaks down blood clots can lead to too much bleeding in people with bleeding disorders, and it aims to help these patients by using special RNA treatments that could make bleeding easier to manage.
-
Investigating blood clotting changes in women using oral contraceptives
This study is looking at how birth control pills might affect blood clotting in women, especially by checking certain proteins in the blood, to help identify those who may be at a higher risk for blood clots.
-
Creating a new therapy using B cells to treat autoimmune diseases
This study is testing a new treatment that uses special B cells to help your immune system be kinder to your body and reduce the chances of autoimmune diseases, and it could be helpful for many people dealing with these conditions.
-
Investigating the role of SIRT5 in Acute Myeloid Leukemia
This study is looking at how a specific protein called SIRT5 influences Acute Myeloid Leukemia (AML) to find new ways to treat this tough blood cancer and help patients feel better.
-
Investigating blood and vascular cell biology for potential therapies
This study is looking at a special protein called PECAM-1 to see how it affects blood vessel health, with the hope of finding new ways to help babies with low platelet counts and improve treatments for conditions like sepsis and poor blood flow.
-
Investigating how different forms of a blood-clotting inhibitor affect bleeding and clotting disorders.
This study is looking at how different forms of a protein called Tissue Factor Pathway Inhibitor (TFPI) help control blood clotting and bleeding, which could lead to better treatments for people with bleeding or clotting disorders like Factor V Leiden.
-
Understanding how kindlin-3 affects platelet function
This study is looking at how a protein called kindlin-3 helps activate another protein in platelets that is important for blood clotting, with the goal of finding new ways to prevent dangerous blood clots, which could help patients with certain blood disorders.
-
Measuring Sirtuin Activity in Cancer Cells
This study is working on a new way to see how certain proteins called sirtuins are working in cancer cells, which could help scientists better understand cancer and develop new treatments.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.